4.62% -0.06

Vivos Therapeutics Inc (VVOS)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Vivos Therapeutics Inc Azioni (VVOS) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-09-30	2025-06-30	2025-03-31	2024-06-30	2024-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	77.57% 6.783	3.82	3.016	4.054	3.419
Cost Of Revenue	66.43% 2.846	1.71	1.507	1.403	0.10
Gross Profit	86.59% 3.937	2.11	1.509	2.651	1.937
Operating Expenses	24.32% 8.671	6.975	5.427	4.587	5.722
Interest Income/Expense	0.50	-	-	-	-
Benefits Costs and Expenses	37.93% 12.18	8.833	6.88	5.984	7.182
Costs And Expenses	37.93% 12.18	8.833	6.88	5.984	7.182
Depreciation and Amortization	25.49% 0.384	0.306	0.177	0.145	0.146
Operating Income/Loss	2.69% -4.734	-4.865	-3.918	-1.936	-3.785
Income/Loss From Continuing Operations Before Tax	7.72% -5.40	-5.013	-3.864	-1.93	-3.763
Income/Loss From Continuing Operations After Tax	7.72% -5.40	-5.013	-3.864	-1.93	-3.763
Net Income/Loss	7.72% -5.40	-5.013	-3.864	-1.93	-3.763
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	20.65% 10.96	9.0872	8.5953	3.2284	2.3082
Diluted Average Shares	20.65% 10.96	9.0872	8.5953	3.2284	2.3082
Basic Earnings Per Share	10.91% -0.49	-0.55	-0.45	-0.60	-1.63
Diluted Earnings Per Share	10.91% -0.49	-0.55	-0.45	-0.60	-1.63
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ZBH

$93.20

0.66%

STE

$214.57

1.05%

DXCM

$64.24

1.56%

PHG

$27.79

1.66%

GEHC

$70.77

0.63%

$81.81

3.31%